Form 4: GeneDx Holdings Corp. CFO Transactions

Kevin Feeley, CFO of GeneDx Holdings Corp., reported transactions involving Class A Common Stock and Restricted Stock Units.

Summary

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp., reported a transaction on June 1, 2026.
• This transaction involved the acquisition of 717 shares of Class A Common Stock through the settlement of Restricted Stock Units (RSUs) with no cost.
• Additionally, 369 shares of Class A Common Stock were disposed of for $51.74 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Feeley beneficially owns 35,290 shares of Class A Common Stock directly.
• He also holds RSUs representing contingent rights to up to 91,702 shares and options to purchase up to 25,906 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to equity compensation and tax obligations, without indicating significant positive or negative developments for the company.

Positives

• The CFO acquired 717 shares of Class A Common Stock through RSU settlement, indicating equity compensation.
• The CFO retains a significant number of shares (35,290) and has substantial unvested RSUs and options, suggesting continued commitment and potential future equity gains.

Negatives

• The CFO sold 369 shares to cover tax withholding, which, while standard, represents a disposition of equity.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts. The transactions reported by the CFO of GeneDx Holdings Corp. are typical for equity compensation plans and tax obligations.

Stakeholder Impact

• Shareholders: The transactions are routine and do not suggest any immediate impact on share price or company strategy. The CFO's continued holdings and unvested equity indicate ongoing alignment with shareholder interests.

Key Dates

Keywords

GeneDx Holdings Corp., Kevin Feeley, Form 4, Class A Common Stock, Restricted Stock Units, RSU, CFO, Insider Trading, SEC Filing, Securities Transaction